Acute Myeloid Leukemia Therapeutics Market is Expected to Reach $ 2.6 bn by 2026
The Global Acute Myeloid Leukemia Therapeutics Market was valued at US$754.38 Million in the year 2018 and is estimated to reach US$2.6 billion by 2026, at a CAGR of 16.9%. Acute Myeloid Leukemia (AML) is one of the most commonly occurring leukemias and accounts for approximately 80% of the leukemia related deaths worldwide. AML is a geneticall... Read More
Multiple Myeloma Treatment Market is Expected to Reach $ 17.5bn by 2026
The Global Multiple Myeloma Treatment Market was valued at US$10.9 billion in the year 2018 and is likely to reach US$17.5 billion by 2026, with a CAGR of 6.1%. Multiple Myeloma is a type of blood cancer that is characterized by cancer formation in the white blood cells otherwise denoted as the plasma cells. Generally, antibodies are produced ... Read More
Liquid Handling Systems Market is Expected to Reach $6.1 bn by 2026
The Liquid Handling Systems Market reached US$3.13 billion at the end of 2018 and is set to reach US$6.01 Billion at the end of 2026, with a CAGR of 8.5%. Generally, liquid handling systems are implemented in clinical laboratories and life science laboratories to reduce the time involved in sample processing, avoid spillages during dispensing, ... Read More
Schizophrenia Drugs Market is Expected to Reach $8.3 bn by 2026
The Global Schizophrenia Drugs Market was valued at US$6.66 billion in the year 2018 and is expected to reach US$8.3 billion by 2026, at a CAGR of 2.79%. Schizophrenia, a disorder of the central nervous system is characterized by the disorientation of thinking, emotions, perceptions, language, etc. It is classified as positive, negative and co... Read More
Urinary Stones Treatment Devices Market is Expected to Reach $1.98 bn by 2026
The Global Urinary Stones Treatment Devices Market was valued at US$1.48 billion in the year 2018 and is expected to reach US$1.98 billion by 2026, at a CAGR of 4.4%. Urinary stones are mainly formed due to the inability of an individual to empty the urinary bladder. Due to urine accumulation, the minerals in the concentrated urine start cryst... Read More
Global Cell Therapy Market is Expected to Reach $8.21 bn by 2026
The Global Cell Therapy Market was valued at US$3.06 billion in the year 2018 and is expected to reach US$8.21 billion by 2026, at a CAGR of 13.1%. Cell therapy offers the promise of treating and altering the course of diseases which cannot be addressed adequately by the existing therapeutic modalities. Initially, blood transfusion was conside... Read More
Global Sleep Apnea Devices Market is Expected to Reach $8.83 bn by 2026
The Sleep Apnea Devices Market reached US$5.1 billion at the end of 2018 and is set to stride over US$8.83 Billion at the end of 2026, with a CAGR of 7.1%. With more than one billion people suffering from sleep apnea, it has become one of the major disorders in recent times. Sleep Apnea is a potential sleep disorder characterized by the repeate... Read More
Global Migraine Drugs Market is Expected to Reach $8.2 bn by 2026
The Global Migraine Drugs Market was valued at US$3.9 billion in the year 2018 and is expected to reach US$8.2 billion by 2026, at a CAGR of 9.73%. Migraine Drugs are a group of medication that is given for the relief of symptoms associated with migraine pain. Around 18 to 19 % of the global populace complain of frequent chronic headaches. In ... Read More
Global Attention Deficit Hyperactivity Disorder (ADHD) Treatment Market is Expected to Reach $24 bn by 2026
The Attention Deficit Hyperactivity Disorder (ADHD) Treatment Market was valued at around US$15 billion at the end of 2018. The revenue is said to engross over US$24 billion by 2026, with a CAGR of 6.1%. ADHD, classified under the diagnostic criteria DSM-5 by the American Psychiatric Association (APA), characterized by patterns of hyperactivit... Read More
Global Antibody Production Market Expected to Reach $23.22 bn by 2026
The Global Antibody Production Market was valued at US$9.93 billion in the year 2018 and is expected to reach US$23.22 billion by 2026, at a CAGR of 12.29%. Antibodies are protein molecules resembling the alphabet ‘Y’. They are innately produced by plasma cells as a primary response and also produced by B cells. They are a part of ... Read More